Submit a Manuscript to the Journal

ImmunoTargets and Therapy

For an Article Collection on

Autoimmune Disease

Manuscript deadline
31 December 2024

Cover image - ImmunoTargets and Therapy

Article collection guest advisor(s)

Professor Michael Schurin, Department of Pathology and Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Submit an ArticleVisit JournalArticles

Autoimmune Disease

Immunotargets and Therapy is pleased to invite you to submit your research to its latest Article Collection on "Autoimmune Disease.”

The Collection, led by Editor-In-Chief Professor Michael Shurin, welcomes relevant Reviews, Original Research and Editorials up until the 31st December 2024. The Collection promises to be a valuable resource for years to come, with articles published alongside some of our finest hot-topic reviews.

Please submit your manuscript on our website, using the promo code ZFWRR for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Autoimmune Diseases” Collection.

While the call is open to receive manuscripts across the broad spectrum of autoimmune diseases, the Editors are particularly interested in manuscripts relating to these key areas:

  • Natural Autoantibodies
  • Autoimmune disorders: New epidemiological data
  • Pathophysiology of autoimmune diseases
  • Novel diagnostic and therapeutic approaches for autoimmune disorders
  • Therapeutic targeting of autoantibodies
  • Clinical utilization of autoantibodies
  • Regulatory immune cells for the treatment of autoimmune diseases
  • Autoantigenomics
  • AI in autoimmunity

View all published papers in this Article Collection here

About the Journal

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

What is the advantage to you of publishing in ImmunoTargets and Therapy?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the website.
  • Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. ImmunoTargets and Therapy has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

PubMed Central
ImmunoTargets and Therapy is indexed on PubMed Central (title abbreviation: Immunotargets Ther). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee. Click here to go through to the Favored Author signup page.

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

Submission Instructions

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal scope and author submission instructions prior to submitting a manuscript. 

The deadline for submitting manuscripts is 31st December 2024.

Upon submission, please use the promo code ZFWRR for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the “Autoimmune Diseases Collection. 

Please contact Ashley Ambros with any queries and discount codes regarding this Article Collection.

Instructions for AuthorsSubmit an Article

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.